“Attributed to the Rising Prevalence of Neuro-degenerative Diseases, the Patient Monitoring Market in the Neuromonitoring Segment Will Be the Fastest Growing Segment in the Next Five Years
The patient monitoring devices market is expected to grow at a CAGR of 5.6% to reach USD 24,762 million by 2020.
The patient monitoring devices form an indispensible part of medical team for every procedure, whether operating in a small clinic or a large multi-specialty hospital. Advanced technology has reduced the size of these monitors drastically with the latest devices being mere grain sized implants. The rising adoption of telemetry and remote monitoring has fueled the growth of patient monitoring devices. The capacity of these devices to monitor patients from long distance, perform intra-operative procedures, and prescribe treatments to patients has reduced discomfort for patients, which has also reduced the hospital stays for patients and reduced the physiciansโ need to travel.
The cardiac monitors segment had the largest share of the total patient monitoring devices market in 2015 and will continue to grow in the next five years to retain the leading position in 2020. The high growth in this segment is attributed to the growing demand for ECG devices. Moreover, rising incidences of cardiac and diseases such as diabetes and hypertension have also contributed to the largest share of the cardiac monitors market. Multi-parameter monitoring devices market was the second largest segment in 2015. These devices can monitor various physiological parameters of a patient in order to have an overview of the patientsโ health and status. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the multi-parameter monitoring devices.
The neuromonitoring devices segment, on the other hand, will be the fastest growing segment in the coming years. With the evolution in technology, neuromonitoring devices can predict the occurrence of neurodegenerative diseases. With growing incidences and increasing awareness of neurodegenerative diseases this market is set to grow at a fast pace. The respiratory monitors segment is also expected to grow at a high pace in the forecast period. Under this segment the capnography products were the fastest growing among all the sub-segments of patient monitoring. Growing number of alternate use of capnographs is the major factor driving the growth of the market. Here the use of capnograph is not limited for intubated patients only but is used for measuring breathing in non-intubated patients. The Remote Patient Monitoring (RPM) devices segment is also poised to grow at a high pace in the coming years, driven by the strict government regulations to restrain the rising healthcare costs.
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data of the various segments in this industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives by governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on the key players in the patient monitoring devices market and the strategies adopted by them to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
โข Market Penetration: Comprehensive information on patient monitoring devices offered by top 10 players in the market. The report analyzes the patent patient monitoring devices market by product and end user across geographies
โข Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the patient monitoring devices market
โข Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various patient monitoring devices across geographies
โข Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the patient monitoring devices market
โข Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the patient monitoring devices market
”
“TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 24
1.5 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 MARKET SIZE ESTIMATION 26
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.2.2 KEY DATA FROM PRIMARY SOURCES 29
2.2.2.1 Key Industry Insights 30
2.2.3 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 35
4.1 PATIENT MONITORING DEVICES MARKET TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD 35
4.2 PATIENT MONITORING MARKET, BY PRODUCT 36
4.3 PATIENT MONITORING MARKET, BY PRODUCT & REGION 36
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Increasing geriatric population to propel the demand for monitoring devices 41
5.2.1.2 Rising incidence of lifestyle diseases 41
5.2.1.3 Growing preference for home and remote monitoring 41
5.2.1.4 Ease-of-use and portability of devices to encourage adoption of point-of-care monitoring devices 41
5.2.2 RESTRAINTS 42
5.2.2.1 Dearth of skilled professionals in patient monitoring 42
5.2.3 OPPORTUNITIES 42
5.2.3.1 Private institutional nursing 42
5.2.3.2 Mergers, acquisitions, and joint ventures 43
5.2.4 CHALLENGES 43
5.2.4.1 Irregular reimbursement scenario 43
6 HEMODYNAMIC MONITORING DEVICES 44
6.1 INTRODUCTION 45
6.1.1 BLOOD PRESSURE MONITORS 46
6.1.2 BLOOD GLUCOSE MONITORS 50
6.1.3 BLOOD GAS AND ELECTROLYTE ANALYZERS 53
6.1.4 CHOLESTEROL ANALYZERS 56
7 NEUROMONITORING DEVICES 59
7.1 INTRODUCTION 60
7.1.1 ELECTROENCEPHALOGRAPH (EEG) 61
7.1.2 TRANSCRANIAL DOPPLER (TCD) 63
7.1.3 MAGNETOENCEPHALOGRAPH (MEG) 65
7.1.4 CEREBRAL OXIMETERS 67
7.1.5 INTRACRANIAL PRESSURE MONITORS (ICP) 69
8 CARDIAC MONITORING DEVICES 71
8.1 INTRODUCTION 72
8.2 ELECTROCARDIOGRAM (ECG) 73
8.3 ECG MARKET, BY PRODUCT TYPE 75
8.3.1 RESTING ECG 76
8.3.1.1 Stress ECG 76
8.3.1.2 Holter monitor 76
8.3.2 WIRED HOLTER MONITORS 76
8.3.3 WIRELESS HOLTER MONITORS 76
8.4 ECG DEVICES MARKET, BY LEAD TYPE 77
8.4.1 SINGLE-LEAD ECG DEVICES 78
8.4.2 3โ6 LEAD ECG DEVICES 78
8.4.3 12-LEAD ECG DEVICES 78
8.4.4 OTHERS 78
8.5 EVENT MONITORS 79
8.6 EVENT MONITORS MARKET, BY PRODUCT TYPE 80
8.6.1 PRE-SYMPTOM (MEMORY LOOP) 81
8.6.2 POST-SYMPTOM EVENT MONITORS 81
8.7 EVENT MONITORS MARKET, BY TECHNOLOGY 82
8.7.1 AUTODETECT MONITORS 82
8.7.2 MANUAL EVENT MONITOR 83
8.8 IMPLANTABLE LOOP RECORDER (ILR) 84
8.9 CARDIAC OUTPUT MONITORING DEVICES 84
8.9.1 MINIMALLY INVASIVE COM DEVICES 85
8.9.2 NON-INVASIVE COM DEVICES 86
9 FETAL AND NEONATAL MONITORING DEVICES 87
9.1 INTRODUCTION 88
9.2 ULTRA SOUND FETAL DOPPLERS 90
9.3 INTERNAL FETAL MONITORS 91
10 RESPIRATORY MONITORING DEVICES 93
10.1 INTRODUCTION 94
10.2 CAPNOGRAPHS 96
10.3 SPIROMETERS 99
10.4 ANESTHESIA MONITORS 102
10.5 SLEEP APNEA MONITORING DEVICES 104
10.6 PULSE OXIMETERS 106
11 MULTI-PARAMETER MONITORING DEVICES 109
11.1 INTRODUCTION 110
11.2 HIGH-ACUITY MONITORS 113
11.3 MID-ACUITY MONITORS 113
11.4 LOW-ACUITY MONITORS 114
12 REMOTE PATIENT MONITORING DEVICES MARKET 115
12.1 INTRODUCTION 116
13 WEIGHT MONITORING DEVICES 118
13.1 INTRODUCTION 119
14 TEMPERATURE MONITORING DEVICES 122
14.1 INTRODUCTION 123
15 PATIENT MONITORING DEVICES MARKET, BY REGION 126
15.1 INTRODUCTION 127
15.2 NORTH AMERICA 129
15.3 EUROPE 134
15.4 ASIA-PACIFIC 138
15.5 REST OF THE WORLD 143
16 COMPETITIVE LANDSCAPE 147
16.1 OVERVIEW 147
16.2 MARKET SHARE ANALYSIS 148
16.2.1 HEMODYNAMIC MONITORS 148
16.2.1.1 Blood pressure monitors 148
16.2.1.2 Single-point blood glucose monitors 149
16.2.1.3 Continuous blood glucose monitors 149
16.2.1.4 Blood gas and electrolyte analyzers 150
16.2.2 NEUROLOGICAL MONITORS 151
16.2.2.1 Electroencephalographs (EEG) 151
16.2.2.2 Transcranial Doppler (TCD) 152
16.2.2.3 Magnetoencephalographs (MEG) 152
16.2.2.4 Cerebral oximetry monitors 153
16.2.2.5 Intracranial pressure (ICP) monitors (Top Players) 154
16.2.3 CARDIAC MONITORS 155
16.2.3.1 Electrocardiographs (ECG) 155
16.2.3.2 Event monitors 156
16.2.3.3 Cardiac output monitors 156
16.2.4 RESPIRATORY MONITORING DEVICES 157
16.2.4.1 Capnographs 157
16.2.4.2 Spirometers 157
16.2.4.3 Anesthesia monitors 158
16.2.4.4 Sleep apnea monitors 158
16.2.4.5 Pulse oximeters 159
16.2.5 FETAL & NEONATAL MONITORS 159
16.2.6 MULTI-PARAMETER MONITORS 160
16.3 COMPETITIVE SITUATION AND TRENDS 161
16.3.1 NEW PRODUCT LAUNCHES AND APPROVALS 161
16.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 162
16.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015 162
16.3.4 ACQUISITIONS AND EXPANSIONS 163
16.3.5 OTHER DEVELOPMENTS 164
17 COMPANY PROFILES 165
17.1 INTRODUCTION 165
17.2 ABBOTT LABORATORIES 166
17.3 ROCHE DIAGNOSTICS 169
17.4 SIEMENS HEALTHCARE 172
17.5 GE HEALTHCARE 175
17.6 MEDTRONIC PLC 178
17.7 PHILIPS HEALTHCARE 182
17.8 LIFEWATCH AG 185
17.9 NIHON KOHDEN CORPORATION 188
17.10 OMRON CORPORATION 190
17.11 HONEYWELL INTERNATIONAL, INC. 192
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
18 APPENDIX 194
18.1 INSIGHTS OF INDUSTRY EXPERTS 194
18.2 DISCUSSION GUIDE 194
18.3 OTHER DEVELOPMENTS 197
18.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 202
18.5 AVAILABLE CUSTOMIZATIONS 204
18.6 RELATED REPORTS 204
“
“LIST OF TABLES
TABLE 1 INCREASING GERIATRIC POPULATION TO DRIVE THE PATIENT MONITORING MARKET 42
TABLE 2 DEARTH OF SKILLED PROFESSIONALS IS RESTRAINING THE MARKET GROWTH 42
TABLE 3 PRIVATE INSTITUTIONAL NURSING PROVIDES MARKET GROWTH OPPORTUNITIES 43
TABLE 4 IRREGULAR REIMBURSEMENT SCENARIO: KEY MARKET CHALLENGE 43
TABLE 5 HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 45
TABLE 6 HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 46
TABLE 7 BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 47
TABLE 8 BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (MILLION UNITS) 48
TABLE 9 BLOOD PRESSURE MONITORS MARKET SIZE, BY TECHNOLOGY,
2013โ2020 (USD MILLION) 48
TABLE 10 BLOOD PRESSURE MONITORS MARKET SIZE, BY SITE OF USAGE,
2013โ2020 (USD MILLION) 48
TABLE 11 BLOOD PRESSURE MONITORS MARKET SIZE, BY SITE OF USAGE,
2013โ2020 (MILLION UNITS) 49
TABLE 12 BLOOD PRESSURE MONITORS MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 49
TABLE 13 BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 50
TABLE 14 BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (MILLION UNITS) 51
TABLE 15 BLOOD GLUCOSE MONITORS MARKET SIZE, BY TYPE, 2013โ2020 (USD MILLION) 51
TABLE 16 BLOOD GLUCOSE MONITORS MARKET SIZE, BY TYPE,
2013โ2020 (MILLION UNITS) 51
TABLE 17 SINGLE-POINT BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 52
TABLE 18 CONTINUOUS BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 52
TABLE 19 BLOOD GLUCOSE MONITORS MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 52
TABLE 20 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 53
TABLE 21 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 54
TABLE 22 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY PRODUCT,
2013โ2020 (THOUSAND UNITS) 54
TABLE 23 POC BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 54
TABLE 24 POC BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013โ2020 (THOUSAND UNITS) 55
TABLE 25 DESKTOP BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 55
TABLE 26 DESKTOP BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013โ2020 (THOUSAND UNITS) 55
TABLE 27 BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 56
TABLE 28 CHOLESTEROL ANALYZERS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 57
TABLE 29 CHOLESTEROL ANALYZERS MARKET SIZE, BY REGION,
2013โ2020 (MILLION UNITS) 57
TABLE 30 CHOLESTEROL ANALYZERS MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 58
TABLE 31 NEUROLOGICAL MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 60
TABLE 32 NEUROMONITORING DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 61
TABLE 33 EEG DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 62
TABLE 34 EEG DEVICES MARKET SIZE, BY REGION, 2013โ2020 (THOUSAND UNITS) 63
TABLE 35 EEG DEVICES MARKET SIZE, BY END USER, 2013โ2020 (USD MILLION) 63
TABLE 36 TRANSCRANIAL DOPPLER MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 64
TABLE 37 TRANSCRANIAL DOPPLER MARKET SIZE, BY REGION, 2013โ2020 (NO. OF UNITS) 65
TABLE 38 TRANSCRANIAL DOPPLER MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 65
TABLE 39 MAGNETOENCEPHALOGRAPH MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 66
TABLE 40 MAGNETOENCEPHALOGRAPH MARKET SIZE, BY REGION,
2013โ2020 (NO. OF UNITS) 66
TABLE 41 MAGNETOENCEPHALOGRAPH MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 67
TABLE 42 CEREBRAL OXIMETERS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 68
TABLE 43 CEREBRAL OXIMETERS MARKET SIZE, BY REGION,
2013โ2020 (THOUSAND UNITS) 68
TABLE 44 CEREBRAL OXIMETERS MARKET SIZE, BY END USER, 2013โ2020 (USD MILLION) 68
TABLE 45 INTRACRANIAL PRESSURE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 69
TABLE 46 INTRACRANIAL PRESSURE MONITORS MARKET SIZE, BY REGION,
2013โ2020 (THOUSAND UNITS) 70
TABLE 47 INTRACRANIAL PRESSURE MONITORS MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 70
TABLE 48 CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2015โ2020 (USD MILLION) 72
TABLE 49 CARDIAC MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (USD MILLION) 73
TABLE 50 ECG DEVICES MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 74
TABLE 51 ECG DEVICES MARKET SIZE, BY REGION, 2015โ2020 (MILLION UNITS) 74
TABLE 52 ECG DEVICES MARKET SIZE, BY PRODUCT, 2015โ2020 (USD MILLION) 75
TABLE 53 ECG DEVICES MARKET SIZE, BY PRODUCT, 2015โ2020 (MILLION UNITS) 75
TABLE 54 ECG DEVICES MARKET SIZE, BY LEAD TYPE, 2015โ2020 (USD MILLION) 77
TABLE 55 ECG DEVICES MARKET SIZE, BY END USER, 2015โ2020 (USD MILLION) 78
TABLE 56 EVENT MONITORS MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 79
TABLE 57 EVENT MONITORS MARKET SIZE, BY REGION, 2015โ2020 (MILLION UNITS) 80
TABLE 58 EVENT MONITORS MARKET SIZE, BY PRODUCT TYPE, 2015โ2020 (USD MILLION) 81
TABLE 59 EVENT MONITORS MARKET SIZE, BY PRODUCT TYPE, 2015โ2020 (MILLION UNITS) 81
TABLE 60 EVENT MONITORS MARKET SIZE, BY TECHNOLOGY, 2015โ2020 (USD MILLION) 82
TABLE 61 EVENT MONITORS MARKET SIZE, BY END USER, 2015โ2020 (USD MILLION) 83
TABLE 62 CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (USD MILLION) 85
TABLE 63 CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (MILLION UNITS) 85
TABLE 64 CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE, BY END USER,
2015โ2020 (USD MILLION) 86
TABLE 65 FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (USD MILLION) 88
TABLE 66 FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (MILLION UNITS) 89
TABLE 67 FETAL AND NEONATAL MONITORING MARKET SIZE, BY PRODUCT TYPE,
2015โ2020 (USD MILLION) 89
TABLE 68 FETAL AND NEONATAL MONITORING MARKET SIZE, BY PRODUCT TYPE,
2015โ2020 (MILLION UNITS) 90
TABLE 69 FETAL AND NEONATAL ULTRASOUND DOPPLERS MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 90
TABLE 70 INTERNAL FETAL MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (USD MILLION) 91
TABLE 71 FETAL AND NEONATAL MONITORING MARKET SIZE, BY APPLICATION,
2015โ2020 (USD MILLION) 91
TABLE 72 FETAL AND NEONATAL MONITORING MARKET SIZE, BY END USER,
2015โ2020 (USD MILLION) 92
TABLE 73 RESPIRATORY MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2015โ2020 (USD MILLION) 94
TABLE 74 RESPIRATORY MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (USD MILLION) 95
TABLE 75 CAPNOGRAPHS MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 96
TABLE 76 CAPNOGRAPHS MARKET SIZE, BY REGION, 2015โ2020 (THOUSAND UNITS) 97
TABLE 77 CAPNOGRAPHS MARKET SIZE, BY TECHNOLOGY, 2015โ2020 (USD MILLION) 97
TABLE 78 CAPNOGRAPHS MARKET SIZE, BY PRODUCT, 2015โ2020 (USD MILLION) 97
TABLE 79 CAPNOGRAPHS MARKET SIZE, BY PRODUCT, 2015โ2020 (THOUSAND UNITS) 98
TABLE 80 CAPNOGRAPHS MARKET SIZE, BY END USER, 2015โ2020 (USD MILLION) 98
TABLE 81 SPIROMETERS MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 99
TABLE 82 SPIROMETERS MARKET SIZE, BY REGION, 2015โ2020 (THOUSAND UNITS) 100
TABLE 83 SPIROMETERS MARKET SIZE, BY TECHNOLOGY, 2015โ2020 (USD MILLION) 100
TABLE 84 SPIROMETERS MARKET SIZE, BY PRODUCT, 2015โ2020 (USD MILLION) 100
TABLE 85 SPIROMETERS DEVICES MARKET SIZE, BY PRODUCT,
2015โ2020 (THOUSAND UNITS) 101
TABLE 86 SPIROMETERS MARKET SIZE, BY END USER, 2015โ2020 (USD MILLION) 101
TABLE 87 ANESTHESIA MONITORS MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 102
TABLE 88 ANESTHESIA MONITORS MARKET SIZE, BY REGION,
2015โ2020 (THOUSAND UNITS) 103
TABLE 89 ANESTHESIA MONITORS MARKET SIZE, BY PRODUCT, 2015โ2020 (USD MILLION) 103
TABLE 90 ANESTHESIA MONITORS MARKET SIZE, BY PRODUCT,
2015โ2020 (THOUSAND UNITS) 103
TABLE 91 ANESTHESIA MONITORS MARKET SIZE, BY END USER, 2015โ2020 (USD MILLION) 104
TABLE 92 SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (USD MILLION) 105
TABLE 93 SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY REGION,
2015โ2020 (THOUSAND UNITS) 105
TABLE 94 SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2015โ2020 (USD MILLION) 105
TABLE 95 SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2015โ2020 (THOUSAND UNITS) 106
TABLE 96 SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY END USER,
2015โ2020 (USD MILLION) 106
TABLE 97 PULSE OXIMETERS MARKET SIZE, BY REGION, 2015โ2020 (USD MILLION) 107
TABLE 98 PULSE OXIMETERS MARKET SIZE, BY REGION, 2015โ2020 (THOUSAND UNITS) 107
TABLE 99 PULSE OXIMETERS MARKET SIZE, BY PRODUCT, 2015โ2020 (USD MILLION) 108
TABLE 100 PULSE OXIMETERS MARKET SIZE, BY PRODUCT, 2015โ2020 (THOUSAND UNITS) 108
TABLE 101 PULSE OXIMETERS MARKET SIZE, BY END USER, 2015โ2020 (USD MILLION) 108
TABLE 102 MULTI-PARAMETER MONITORING DEVICES MARKET SIZE BY REGION,
2013โ2020 (USD MILLION) 110
TABLE 103 MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (THOUSAND UNITS) 111
TABLE 104 MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY,
2013โ2020 (USD MILLION) 112
TABLE 105 MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY,
2013โ2020 (THOUSAND UNITS) 112
TABLE 106 MULTI-PARAMETER HIGH-ACUITY MONITORING DEVICES MARKET SIZE,
BY REGION, 2013โ2020 (USD MILLION) 113
TABLE 107 MULTI-PARAMETER MID-ACUITY MONITORING DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 113
TABLE 108 MULTI-PARAMETER LOW-ACUITY MONITORING DEVICES MARKET SIZE,
BY REGION, 2013โ2020 (USD MILLION) 114
TABLE 109 MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 114
TABLE 110 REMOTE PATIENT MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 117
TABLE 111 REMOTE PATIENT MONITORING DEVICES MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 117
TABLE 112 WEIGHT MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 119
TABLE 113 WEIGHT MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (MILLION UNITS) 120
TABLE 114 WEIGHT MONITORING DEVICES MARKET SIZE, BY TYPE,
2013โ2020 (USD MILLION) 120
TABLE 115 WEIGHT MONITORING DEVICES MARKET SIZE, BY TYPE,
2013โ2020 (MILLION UNITS) 120
TABLE 116 WEIGHT MONITORING DEVICES MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 121
TABLE 117 TEMPERATURE MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 123
TABLE 118 TEMPERATURE MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (MILLION UNITS) 124
TABLE 119 TEMPERATURE MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 124
TABLE 120 TEMPERATURE MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (MILLION UNITS) 124
TABLE 121 TEMPERATURE MONITORING DEVICES MARKET SIZE, BY END USER,
2013โ2020 (USD MILLION) 125
TABLE 122 PATIENT MONITORING DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 129
TABLE 123 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 131
TABLE 124 NORTH AMERICA: HEMODYNAMIC MONITORING DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 132
TABLE 125 NORTH AMERICA: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 132
TABLE 126 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 132
TABLE 127 NORTH AMERICA: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 133
TABLE 128 NORTH AMERICA: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 133
TABLE 129 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE,
BY ACUITY, 2013โ2020 (USD MILLION) 133
TABLE 130 NORTH AMERICA: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 134
TABLE 131 EUROPE: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 135
TABLE 132 EUROPE: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 136
TABLE 133 EUROPE: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 136
TABLE 134 EUROPE: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 136
TABLE 135 EUROPE: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 137
TABLE 136 EUROPE: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 137
TABLE 137 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013โ2020 (USD MILLION) 137
TABLE 138 EUROPE: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 138
TABLE 139 ASIA-PACIFIC: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 140
TABLE 140 ASIA-PACIFIC: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 141
TABLE 141 ASIA-PACIFIC: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 141
TABLE 142 ASIA-PACIFIC: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 141
TABLE 143 ASIA-PACIFIC: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 142
TABLE 144 ASIA-PACIFIC: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 142
TABLE 145 ASIA-PACIFIC: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE,
BY ACUITY, 2013โ2020 (USD MILLION) 142
TABLE 146 ASIA-PACIFIC: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 143
TABLE 147 ROW: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 144
TABLE 148 ROW: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 144
TABLE 149 ROW: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 145
TABLE 150 ROW: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 145
TABLE 151 ROW: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 145
TABLE 152 ROW: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 146
TABLE 153 ROW: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY,
2013โ2020 (USD MILLION) 146
TABLE 154 ROW: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 146
TABLE 155 MAJOR PLAYERS โ MEG, 2014 152
TABLE 156 MAJOR PLAYERS โ INTRACRANIAL PRESSURE MONITORS, 2014 154
TABLE 157 SPIROMETERS MARKET: MAJOR PLAYERS, 2014 157
TABLE 158 NEW PRODUCT LAUNCHES & APPROVALS, 2012โ2015 161
TABLE 159 ACQUISITIONS AND EXPANSIONS, 2012-2015 163
TABLE 160 OTHER DEVELOPMENTS, 2012โ2015 164
“
“LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 25
FIGURE 2 MARKET SIZE ESTIMATION APPROACH 27
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 28
FIGURE 5 PATIENT MONITORING DEVICES MARKET SNAPSHOT (2015 VS. 2020) 31
FIGURE 6 ECG DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD 32
FIGURE 7 EEG SEGMENT WILL GROW AT A FASTEST PACE IN THE FORECAST PERIOD 32
FIGURE 8 GEOGRAPHICAL SNAPSHOT: HIGH-GROWTH EXPECTED IN EMERGING MARKETS ACROSS ASIA-PACIFIC DURING THE FORECAST PERIOD 33
FIGURE 9 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, THE DOMINANT STRATEGIES IN THE MARKET 34
FIGURE 10 CARDIAC MONITORING DEVICES ACCOUNTS FOR THE LARGEST MARKET SHARE
IN 2015 36
FIGURE 11 BLOOD PRESSURE MONITORING DEVICES SEGMENT DOMINATES PATIENT MONITORING MARKET IN 2015 36
FIGURE 12 RESTING ELECTROCARDIOGRAM (ECG) DOMINATES ECG SEGMENT 37
FIGURE 13 ELECTROENCEPHALOGRAPH (EEG) SEGMENT TO WITNESS HIGHEST GROWTH IN THE NEUROMONITORING DEVICES MARKET 37
FIGURE 14 RESPIRATORY MONITORING DEVICES MARKET: CAPNOGRAPHY MONITORS WILL REGISTER THE HIGHEST GROWTH RATE 38
FIGURE 15 INCREASING GERIATRIC POPULATION AND INCIDENCE OF LIFESTYLE DISEASES TO DRIVE THE PATIENT MONITORING MARKET GROWTH 40
FIGURE 16 BLOOD PRESSURE MONITORS TO DOMINATE THE HEMODYNAMIC MONITORING DEVICES MARKET IN 2015 45
FIGURE 17 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING DEVICES MARKET DURING THE FORECAST PERIOD 46
FIGURE 18 NORTH AMERICA TO DOMINATE THE BLOOD PRESSURE MONITORS MARKET
IN 2015 47
FIGURE 19 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE BLOOD GLUCOSE MONITORS MARKET DURING THE FORECAST PERIOD 50
FIGURE 20 NORTH AMERICA TO DOMINATE THE BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET IN 2015 53
FIGURE 21 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE CHOLESTEROL ANALYZERS MARKET DURING THE FORECAST PERIOD 57
FIGURE 22 EEG DEVICES TO DOMINATE THE NEUROLOGICAL MONITORING DEVICES MARKET IN 2015 60
FIGURE 23 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN THE NEUROMONITORING DEVICES MARKET DURING THE FORECAST PERIOD 61
FIGURE 24 NORTH AMERICA TO DOMINATE THE ECG DEVICES MARKET IN 2015 62
FIGURE 25 ASIA-PACIFIC REGION TO WITNESS HIGHEST GROWTH IN THE TRANSCRANIAL DOPPLER MARKET 64
FIGURE 26 NORTH AMERICA TO DOMINATE THE MAGNETOENCEPHALOGRAPH MARKET
IN 2015 66
FIGURE 27 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE CEREBRAL OXIMETERS MARKET 67
FIGURE 28 NORTH AMERICA IS EXPECTED TO DOMINATE THE INTRACRANIAL PRESSURE MONITORS MARKET IN 2015 69
FIGURE 29 ECG DEVICES SEGMENT EXPECTED TO DOMINATE THE CARDIAC MONITORING DEVICES MARKET IN 2015 72
FIGURE 30 ASIA-PACIFIC ECG MARKET IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 73
FIGURE 31 RESTING MONITORS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 75
FIGURE 32 3-6 LEAD TYPE ECG DEVICES EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 77
FIGURE 33 NORTH AMERICA TO DOMINATE THE EVENT MONITORS MARKET IN 2015 79
FIGURE 34 PRE-EVENT MONITORS ARE EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 80
FIGURE 35 AUTODETECT EVENT MONITORS TO DOMINATE THE EVENT MONITORING DEVICES MARKET IN 2015 82
FIGURE 36 HOME SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 83
FIGURE 37 NORTH AMERICA TO DOMINATE THE EVENT MONITORS MARKET IN 2015 84
FIGURE 38 HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 86
FIGURE 39 NORTH AMERICA TO DOMINATE THE FETAL AND NEONATAL MONITORING DEVICES MARKET IN 2015 88
FIGURE 40 FETAL AND NEONATAL ULTRASOUND DOPPLER SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 89
FIGURE 41 ANESTHESIA MONITORS TO DOMINATE THE RESPIRATORY MONITORING DEVICES MARKET IN 2015 94
FIGURE 42 ASIA-PACIFIC MARKET EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 95
FIGURE 43 NORTH AMERICA TO DOMINATE THE CAPNOGRAPHS MARKET IN 2015 96
FIGURE 44 ASIA-PACIFIC REGION IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 99
FIGURE 45 NORTH AMERICA TO DOMINATE THE ANESTHESIA MONITORS MARKET IN 2015 102
FIGURE 46 NORTH AMERICA DOMINATES THE MARKET FOR SLEEP APNEA MONITORING DEVICES IN 2015 104
FIGURE 47 NORTH AMERICA DOMINATES THE PULSE OXIMETERS MARKET IN 2015 107
FIGURE 48 NORTH AMERICA DOMINATED THE MULTI-PARAMETER MONITORING DEVICES MARKET IN 2015 110
FIGURE 49 LOW-ACUITY DEVICES DOMINATED THE MULTI-PARAMETER MONITORING MARKET IN 2015 111
FIGURE 50 NORTH AMERICA DOMINATED THE REMOTE PATIENT MONITORING DEVICES MARKET IN 2015 116
FIGURE 51 EUROPE DOMINATED THE GLOBAL WEIGHT MONITORING DEVICES MARKET
IN 2015 119
FIGURE 52 NORTH AMERICA DOMINATED THE TEMPERATURE MONITORING DEVICES MARKET IN 2015 123
FIGURE 53 GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE PATIENT MONITORING EQUIPMENT/DEVICES/SYSTEMS MARKET 127
FIGURE 54 ASIA-PACIFIC MARKET FOR PATIENT MONITORING DEVICES TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES 128
FIGURE 55 NORTH AMERICA WILL CONTINUE TO DOMINATE THE PATIENT MONITORING DEVICES MARKET IN THE FORECAST PERIOD 128
FIGURE 56 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT 130
FIGURE 57 NEUROMONITORING DEVICES SEGMENT TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN PATIENT MONITORING DEVICES MARKET 131
FIGURE 58 CARDIAC MONITORING DEVICES WILL CONTINUE TO DOMINATE THE EUROPEAN PATIENT MONITORING DEVICES MARKET 135
FIGURE 59 ASIA-PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT 139
FIGURE 60 RPM DEVICES SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE APAC PATIENT MONITORING DEVICES MARKET 140
FIGURE 61 CARDIAC MONITORING DEVICES WILL CONTINUE TO DOMINATE THE PATIENT MONITORING DEVICES MARKET IN THE REST OF THE WORLD REGION 143
FIGURE 62 NEW PRODUCT LAUNCHES & APPROVALS WAS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE LAST THREE YEARS (2012-2015) 147
FIGURE 63 GLOBAL BLOOD PRESSURE MONITORS MARKET SHARE, BY KEY PLAYER, 2014 148
FIGURE 64 GLOBAL SINGLE-POINT BLOOD GLUCOSE MONITORS MARKET SHARE, BY KEY PLAYER, 2014 149
FIGURE 65 GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORS MARKET SHARE, BY KEY PLAYER, 2014 149
FIGURE 66 GLOBAL BLOOD GAS & ELECTROLYTE ANALYZERS MARKET SHARE, BY KEY PLAYER, 2014 150
FIGURE 67 GLOBAL EEG MARKET SHARE, BY KEY PLAYER, 2014 151
FIGURE 68 GLOBAL TCD MARKET SHARE, BY KEY PLAYER, 2014 152
FIGURE 69 GLOBAL CEREBRAL OXIMETRY MONITORS MARKET SHARE, BY KEY PLAYER, 2014 153
FIGURE 70 GLOBAL ECG MARKET SHARE, BY KEY PLAYER, 2014 155
FIGURE 71 GLOBAL EVENT MONITORS MARKET SHARE, BY KEY PLAYER, 2014 156
FIGURE 72 GLOBAL CARDIAC MONITORS MARKET SHARE, BY KEY PLAYER, 2014 156
FIGURE 73 GLOBAL CAPNOGRAPHS MARKET SHARE, BY KEY PLAYER, 2014 157
FIGURE 74 GLOBAL ANESTHESIA MONITORS MARKET SHARE, BY KEY PLAYER, 2014 158
FIGURE 75 GLOBAL SLEEP APNEA MONITORS MARKET SHARE, BY KEY PLAYER, 2014 158
FIGURE 76 GLOBAL PULSE OXIMETERS MARKET SHARE, BY KEY PLAYER, 2014 159
FIGURE 77 GLOBAL FETAL & NEONATAL MONITORS MARKET SHARE, BY KEY PLAYER, 2014 159
FIGURE 78 GLOBAL MULTI-PARAMETER MONITORS MARKET SHARE, BY KEY PLAYER, 2014 160
FIGURE 79 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES AND APPROVALS WAS THE KEY GROWTH STRATEGY 161
FIGURE 80 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS 165
FIGURE 81 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 169
FIGURE 82 SIEMENS HEALTHCARE: COMPANY SNAPSHOT 172
FIGURE 83 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 182
FIGURE 84 LIFEWATCH AG: COMPANY SNAPSHOT 185
FIGURE 85 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 188
FIGURE 86 OMRON CORPORATION: COMPANY SNAPSHOT 190
FIGURE 87 HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT 192
“
